TRIM24 and esophageal squamous cell carcinoma: We also found that TRIM24 expression is a significant predictor for OS and DFS in patients with well-differentiated ESCC (OS, P = 0.003; DFS, P = 0.012; Fig. 3C) or earlier pTNM stage (I-II) (OS, P = 0.021; DFS, P = 0.017; Fig. 3D), but not in those with moderate/poor differentiation or advanced pTNM stage (III) (Supplemental Fig. 1).